Preclinical studies have shown that radiation therapy synergistically enhances the antitumor effects of immunotherapy, such as with immune checkpoint inhibitors (ICIs), by increasing tumor infiltration and upregulating PD-L1 expression [1, 2]. The gene discussed is CD274; the disease is neoplasm.